FDBusiness.com

A new, proprietary formulation of slow-release genistein, tomato lycopene and vitamin D for bone health

 Breaking News
  • Diageo to Acquire British Distillery Spread the loveDiageo announces it has reached agreement to acquire Herefordshire-based Chase Distillery, the owner of Chase GB Gin and the award-winning Chase Original Potato Vodka. Founded in 2008 by...
  • Tate & Lyle to Expand Tapioca Production Spread the loveTate & Lyle, a leading global provider of food and beverage ingredients and solutions, is to acquire an 85% shareholding in Chaodee Modified Starch Co, a well-established tapioca...
  • Coca-Cola European Partners to acquire Coca-Cola Amatil Spread the loveCoca-Cola European Partners, the world’s largest Coke bottler based on revenue, has agreed to acquire Coca-Cola Amatil, one of the largest bottlers and distributors of ready-to-drink beverages and...
  • Treatt Partners With Siemens to Power Digitalisation at New Global Headquarters Spread the loveTreatt, an ingredients manufacturer and solutions provider to the global flavour, fragrance and consumer goods markets, has partnered with Siemens Digital Industries (DI) to build a world class...
  • Diageo Introduces ‘Guinness 0.0’ Spread the loveDiageo has launched Guinness 0.0, a new non-alcoholic beer from the brewers at St James’s Gate in Dublin that boasts the same beautifully smooth taste, perfectly balanced flavour...

A new, proprietary formulation of slow-release genistein, tomato lycopene and vitamin D for bone health

February 27
11:40 2013
Spread the love

The innovative formulation contains clinically tested ingredients

LycoRed,Israel, launches Lyc-O-Fem™, a slow-release formulation containing genistein in a new proprietary composition for bone health. The combo also provides a natural approach to alleviate menopause symptoms. Lyc-O-Fem™ is the first in LycoRed’s new line of innovative products combining slow-release technology with genistein, tomato lycopene and an effective dose of vitamin D3. All three are clinically proven nutrients to support bone health.

The genistein in Lyc-O-Fem™ is a phytoestrogen derived from sophora japonica, the Japanese pagoda tree, and is standardized to 98% purity and specially formulated for slow release. The compound has been shown in research studies to support bone health and reduce vasomotor symptoms. Studies back the positive effect of genistein on bone metabolism in post-menopausal women, without the harmful estrogenic activity. But genistein is rapidly metabolized, requiring a twice-daily administration of the supplement. The slow-release technology in Lycored’s preparation provides a continuous exposure, allowing once-a-day supplementation.

“The advantage in combining the slow-release formulation of pure genistein with natural tomato lycopene, in addition to the cumulative activity in bone maintenance, is the ability of lycopene derivatives to reduce the risk of certain adverse effects associated with estrogenic activity,” explains Tal Offer, PhD, Product Development Manager of LycoRed. Lycopene is a bright-red carotenoid pigment; Lyc-O-Fem™ contains lycopene from an all-natural extract of tomatoes. To develop a strain of non-genetically modified tomatoes rich in lycopene—up to four times the amount found in regular tomatoes—conventional cross-breeding methods were used and a proprietary method for extracting the tomato lycopene from these tomatoes was developed. Lyc-O-Fem™ is available as a (drum-to-hopper) pre-mix, in hard-shell capsules or as a bulk or fully packed product.


Warning: count(): Parameter must be an array or an object that implements Countable in /home/fdbusiness/public_html/wp-content/themes/legatus-theme/includes/single/post-tags.php on line 5

About Author

colin

colin

Related Articles

Food & Drink Business Conference & Exhibition 2016

find food jobs

The Magazine

F&D Business Preferred Suppliers

New Subscriber

Subscribe Here



Advertisements